SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Roundhill ETF Trust - Roundhill Memory ETF

Roundhill Memory ETF is facing significant volatility as investors digest a massive sell-off in South Korean memory giants, even as robust earnings and strong institutional demand for the upcoming SK Hynix ADR debut signal underlying sector strength. Community sentiment remains deeply polarized between those viewing the decline as a major buying opportunity driven by AI infrastructure demand and those fearing a cyclical peak or further downside due to broader market turbulence.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is drawing intense market attention with its high-profile Nasdaq debut, as investors weigh its dominance in the crucial HBM sector against concerns of potential volatility and IPO premium pricing. While the community is divided between those positioning for a long-term AI-driven supercycle and those wary of institutional exit liquidity, active discussions are centered on its competitive relationship with Micron and the potential for a broader memory sector re-rating.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as institutional investors aggressively accumulate shares amid record inflows into semiconductor ETFs and positive sentiment surrounding the H200 GPU export potential. The community is actively debating the durability of the AI infrastructure cycle, with bulls pointing to fundamental dominance and institutional support while bears highlight valuation concerns and geopolitical risks.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is facing intense downward pressure driven by sector-wide rotation out of space equities and ongoing share dilution, causing significant friction among investors debating whether to buy the dip or exit. The community remains deeply polarized, with bulls pointing to a robust contract backlog and long-term space infrastructure growth, while bears highlight the stock's persistent technical weakness and aggressive short selling.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

The Direxion Daily South Korea Bull 3X Shares (KORU) is experiencing extreme volatility as investors react to a major sell-off in the South Korean KOSPI index, which was triggered by concerns over forced liquidations and potential regulatory crackdowns on leveraged ETFs. Community members are actively debating whether this sharp decline represents a forced deleveraging event or a temporary technical adjustment, with many traders looking for entry points ahead of upcoming catalysts like the SK Hynix IPO and a planned stock split.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as market sentiment shifts following the U.S. listing of competitor SK Hynix, sparking community debate over long-term memory supply cycles versus AI-driven demand. Investors are actively discussing the stock's valuation, key support levels, and the durability of the AI memory supercycle in the face of ongoing geopolitical uncertainty and recent market volatility.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are weighing escalating tensions in the Middle East and the closure of the Strait of Hormuz against hopes for continued AI-driven profitability and upcoming corporate earnings. While the community is actively debating the potential for a market pullback versus a reflexive dip-buying rally, sentiment remains divided between fears of geopolitical instability and the historical tendency for the market to remain resilient.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending due to heightened volatility following a series of insider share sales and sector-wide weakness triggered by SpaceXs market performance, though bulls remain focused on the company's recent successful U.S. Space Force mission and its long-term potential as a vertically integrated space infrastructure player. Community discussion is heavily divided between those viewing the current pullback as a tactical buying opportunity near established support levels and those expressing frustration over the stock's recent downward momentum and CEO share liquidation.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors weigh significant long-term growth potential from its strategic manufacturing joint venture with Toyota against ongoing concerns regarding high cash burn and volatility. Community sentiment remains polarized, with many bulls focusing on upcoming FAA certification milestones and commercial launch plans while bears continue to highlight dilution risks and the impact of intense short selling.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

LABU is currently trending as a primary vehicle for retail and institutional traders to gain leveraged exposure to a potential biotech sector rotation, fueled by ongoing M&A activity and the community's anticipation of renewed sector momentum. Investors are closely monitoring the index's ability to maintain support levels, while actively discussing the potential for a broader market rotation into biotech as tech valuations face scrutiny.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Medicus Pharma Ltd. (MDCX) Stock Gaining Momentum With Innovative Skin Cancer Treatment Technology?

Is Medicus Pharma Ltd. (MDCX) Stock Gaining Momentum With Innovative Skin Cancer Treatment Technology...

Medicus Pharma To Highlight SkinJect Phase 2 Data And Teverelix Clinical Advances At BIO 2026

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeuticread more...

Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook

Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook...

EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline

Medicus Pharma to present Phase 1 Teverelix data showing dose-dependent estradiol suppression and long-acting profile at AACE 2026.read more...

EXCLUSIVE: Medicus Pharma Refines Trial Design To Cut Costs, Accelerate Development For Enlarged Prostate Patients

Medicus Pharma submits Phase 2 design for Teverelix, targeting faster data readouts and lower costs in benign prostatic hyperplasiaread more...

Power Hour Surge: Biotech Cash Floods, Energy Breakouts, and AI Bets Drive the Stocks to Watch into the Close

As Wall Street heads into the final stretch of the trading day, capital flows into biotech financing, clean energy, and emerging technology platforms are shaping the stocks traders are watching most closely into the close and after-hours session. $EONR, $SAFX, $KBLB, $HIMS, $MDCX, $ANTX, $NVO, $MDCX, $RLMD, $SLDB, $ANTX, $EDIT, $DDD

Dow Falls Over 300 Points; Kroger Posts Mixed Results

US stocks down, Dow falls 300 points. Dow traded at 48,411.44, NASDAQ at 22,741.80, S&P 500 at 6,847.63. Energy shares rise, healthcare stocks dip. Kroger posts mixed results. Equities up for Impact...

Medicus Pharma Stock Swings After Skin Cancer Treatment Results

Medicus Pharma stock surged then slipped after the Phase 2 trial showed a 73% clearance rate for its skin cancer treatment.read more...

Medicus Pharma Ltd. is a biotech life sciences company, which focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. It develops a product, SkinJectTM, with an indication for basal cell carcinoma. The company was founded on April 30, 2008 and is headquartered in Toronto, Canada.

Medicus Pharma Ltd

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.4076
Prev Close	$0.4225
Open	$0.4224
Dividend Yield	0.00%
50-Day Moving Average	$0.3557
Beta	0.00
Avg. Volume	2.27M
PE Ratio	-0.23

52-Week High	$3.35
52-Week Low	$0.25
Market Capitalization	$23.09M
EPS (Annual)	-$1.96
Price to Book	17.15
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

MDCXMedicus Pharma Ltd

Latest MDCX News